Moreover, Fujii et al. noted that patients with relatively preserved nutritional status, as indicated by a low Controlling Nutritional Status score calculated from serum albumin, total lymphocyte count, and total cholesterol levels, demonstrated significantly greater benefits from anamorelin across four cancer types for which anamorelin is approved for insurance coverage [15]. Here, ALB is linked to cancer.